Two Sigma Advisers’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Buy |
381,300
+207,500
| +119% | +$2.33M | 0.01% | 789 |
|
|
2025
Q1 | $794K | Sell |
173,800
-119,400
| -41% | -$546K | ﹤0.01% | 1573 |
|
|
2024
Q4 | $1.65M | Buy |
293,200
+108,600
| +59% | +$613K | ﹤0.01% | 1213 |
|
|
2024
Q3 | $893K | Sell |
184,600
-54,100
| -23% | -$262K | ﹤0.01% | 1464 |
|
|
2024
Q2 | $1.16M | Buy |
238,700
+202,000
| +550% | +$986K | ﹤0.01% | 1474 |
|
|
2024
Q1 | $487K | Buy |
+36,700
| New | +$487K | ﹤0.01% | 1882 |
|